FASTING CANCER

  1. Fasting and cancer : molecular mechanisms and clinical application
  2. Fasting and cancer treatment in humans: A case series report
  3. Effects of short-term Fasting on cancer treatment
  4. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients
  5. Fasting glucose is a risk factor for breast cancer : a prospective study
  6. Fasting insulin and outcome in early-stage breast cancer : results of a prospective cohort study
  7. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy
  8. Fasting serum glucose level and cancer risk in Korean men and women
  9. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
  10. Prolonged nightly Fasting and breast cancer prognosis
  11. Intermittent Fasting in the prevention and treatment of cancer
  12. Fasting -mimicking diet and hormone therapy induce breast cancer regression
  13. Fasting -mimicking diet and markers/risk factors for aging, diabetes, cancer , and cardiovascular disease
  14. A review of Fasting effects on the response of cancer to chemotherapy
  15. Fasting and caloric restriction in cancer prevention and treatment
  16. Autophagy and intermittent Fasting : the connection for cancer therapy?
  17. Fasting to enhance cancer treatment in models: the next steps
  18. The effect of caloric restriction and Fasting on cancer
  19. Fasting plasma amino acid levels in cancer patients
  20. Fibrinogen synthesis is elevated in Fasting cancer patients with an acute phase response
  21. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis
  22. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to Fasting and improve chemotherapeutic index
  23. Prolonged nightly Fasting and breast cancer risk: findings from NHANES (2009–2010)
  24. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and Fasting glucose values prior to …
  25. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients
  26. The effects of short-term Fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
  27. Energy and caloric restriction, and Fasting and cancer : a narrative review
  28. Fasting -mimicking diet plus chemotherapy in breast cancer treatment
  29. The effects of short-term Fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer : a randomized cross-over pilot …
  30. Current Evidence and Directions for Intermittent Fasting During cancer Chemotherapy
  31. Fasting C-peptide levels and death resulting from all causes and breast cancer : the health, eating, activity, and lifestyle study
  32. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of Fasting and feeding
  33. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
  34. Temporal association of changes in Fasting blood glucose and body mass index with diagnosis of pancreatic cancer
  35. Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models
  36. … term Fasting and its combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer
  37. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
  38. Fasting Plasma Glucose and Incident Colorectal cancer : Analysis of a Nationwide Epidemiological Database
  39. Metabolic regulation of Sirtuins upon Fasting and the implication for cancer
  40. Roles of caloric restriction, ketogenic diet and intermittent Fasting during initiation, progression and metastasis of cancer in animal models: a systematic review …
  41. … of exercise training on Fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer
  42. Effect of intermittent Fasting on prostate cancer tumor growth in a mouse model
  43. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer : a cohort study
  44. Diet and chemotherapy: the effects of Fasting and ketogenic diet on cancer treatment
  45. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models
  46. Fasting -induced differential stress sensitization in cancer treatment
  47. Impact of Fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study
  48. Fasting reduces intestinal radiotoxicity, enabling dose-escalated radiation therapy for pancreatic cancer
  49. Fasting , fats, and physics: combining ketogenic and radiation therapy against cancer
  50. The incremental risk of pancreatic cancer according to Fasting glucose levels: Nationwide population-based cohort study
  51. Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages
  52. High Fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease
  53. Could intermittent energy restriction and intermittent Fasting reduce rates of cancer in obese, overweight, and normal-weight subjects? A summary of evidence
  54. Enhanced therapeutic efficacy in cancer patients by short-term Fasting : the autophagy connection
  55. Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells
  56. The association between Fasting blood glucose and the risk of primary liver cancer in Chinese males: a population-based prospective study
  57. Fasting -Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with cancer
  58. Fasting : starving cancer
  59. Metformin induces a Fasting -and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
  60. A linear dose-response relationship between Fasting plasma glucose and colorectal cancer risk: systematic review and meta-analysis
  61. Short-Term Fasting accompanying chemotherapy as a supportive therapy in gynecological cancer : protocol for a multicenter randomized controlled clinical trial
  62. Fasting -mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
  63. Effect of intermittent Fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice
  64. The effect of Fasting on the important molecular mechanisms related to cancer treatment
  65. Effect of home-based exercise intervention on Fasting insulin and adipocytokines in colorectal cancer survivors: a randomized controlled trial
  66. Fasting glucose and risk of colorectal cancer in the Korean Multi-center cancer Cohort
  67. Association between Fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean cancer Prevention Study-II
  68. Ramadan Fasting and patients with cancer : state-of-the-art and future prospects
  69. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent …
  70. Perioperative Fasting time among cancer patients submitted to gastrointestinal surgeries
  71. Obesity, weight change, Fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer : the Rancho Bernardo …
  72. Fasting -mimicking diet is safe and reshapes metabolism and antitumor immunity in cancer patients
  73. Quality of life and illness perceptions in patients with breast cancer using a Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 …
  74. Influence of Fasting glucose level on gastric cancer incidence in a prospective cohort study
  75. The prognostic influence of body mass index, resting energy expenditure and Fasting blood glucose on postoperative patients with esophageal cancer
  76. The association between Fasting blood glucose trajectory and cancer risk in Chinese population without diabetes
  77. Longitudinal changes in Fasting plasma glucose are associated with risk of cancer mortality: A Chinese cohort study
  78. Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort
  79. Tumour necrosis factor-alpha, interleukin-6, and Fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy
  80. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate cancer
  81. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: The Malmö Diet and cancer study
  82. Fasting plus tyrosine kinase inhibitors in cancer
  83. Fasting but not casual blood glucose is associated with pancreatic cancer mortality in Japanese: EPOCH-JAPAN
  84. Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single-Dose Administration Under Fasting Conditions in Prostate cancer
  85. The impact of a Fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer : a pilot implementation study
  86. Fasting among Muslim cancer patients during the holy month of Ramadan
  87. Annual Fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study
  88. Cigarette smoking, elevated Fasting serum glucose, and risk of pancreatic cancer in Korean men
  89. Intermittent and periodic Fasting , hormones, and cancer prevention
  90. Fasting and weight‐loss restrictive diet practices among 2,700 cancer survivors: results from the NutriNet‐Santé cohort
  91. Fasting plasma glucose variability and gastric cancer risk in individuals without diabetes mellitus: A nationwide population-based cohort study
  92. Fasting serum glucose level and gastric cancer risk in a nested case-control study
  93. Fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: the Fujian prospective investigation of cancer (FIESTA …
  94. Fasting blood glucose, cholesterol, and risk of primary liver cancer : the kailuan study
  95. Predictors of Fasting serum insulin and glucose and the risk of pancreatic cancer in smokers
  96. Short-Term Fasting Synergizes with Solid cancer Therapy by Boosting Antitumor Immunity
  97. The behavior of Turkish cancer patients in Fasting during the holy month of Ramadan
  98. Fasting serum levels of potassium and sodium in relation to long-term risk of cancer in healthy men
  99. … of peroxisome proliferator-activated receptor (PPAR) γ Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired Fasting glucose (IFG) in …
  100. Elevated Fasting blood glucose is associated with increased risk of breast cancer : outcome of case-control study conducted in Karachi, Pakistan
  101. Fasting blood glucose and risk of prostate cancer : A systematic review and meta-analysis of dose-response
  102. Fasting blood glucose and lipid profile alterations following twelve-month androgen deprivation therapy in men with prostate cancer
  103. Annual Fasting ; the early calories restriction for cancer prevention
  104. Fasting Blood Glucose Variability and Unfavorable Trajectory Patterns Are Associated with the Risk of Colorectal cancer
  105. Adiposity and estrogen receptor‐positive, postmenopausal breast cancer risk: Quantification of the mediating effects of Fasting insulin and free estradiol
  106. Liver cancer is induced by a subnecrogenic dose of DENA when associated with Fasting /refeeding: role of glutathione-transferase and lipid peroxidation
  107. Does Fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?
  108. Comparison of the pharmacokinetics of erlotinib administered in complete Fasting and 2 h after a meal in patients with lung cancer
  109. Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study
  110. Fasting serum glucose and subsequent liver cancer risk in a Korean prospective cohort
  111. Pilot study to assess prolonged overnight Fasting in breast cancer survivors (longfast)
  112. Increased Fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer
  113. Fasting blood glucose levels and prognosis in patients with non-small-cell lung cancer : a prospective cohort study in China
  114. Association of Fasting serum insulin and cancer mortality in a healthy population–28-year follow-up of the French TELECOM Study
  115. Effects of Fasting on 18F-DCFPyL uptake in prostate cancer lesions and tissues with known high physiologic uptake
  116. Fasting plasma carotenoids concentrations in Crohn’s and pancreatic cancer patients compared to control subjects
  117. Associations between Christian Orthodox Church Fasting and Adherence to the World cancer Research Fund’s cancer Prevention Recommendations
  118. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to Fasting glucose in Chinese colorectal cancer
  119. Fasting serum glucose, thyroid‐stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer : A case‐control study
  120. The Association of Nighttime Fasting Duration and Prostate cancer Risk: Results from the Multicase-Control (MCC) Study in Spain
  121. Abbreviated preoperative Fasting favours postoperative oral intake at lower hospital admission costs for cancer patients.
  122. Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality
  123. Variation in Fasting and non-Fasting serum enterolactone concentrations in women of the Malmö diet and cancer cohort
  124. Author Correction: Fasting -mimicking diet and hormone therapy induce breast cancer regression
  125. A Fasting -mimicking diet and vitamin C: turning anti-aging strategies against cancer
  126. Feasibility of” no tube no Fasting ” therapy in thoracolaparoscopic oesophagectomy for patients with oesophageal cancer
  127. Influence of pre-operative oral carbohydrate loading vs. standard Fasting on tumor proliferation and clinical outcome in breast cancer patients─ a randomized …
  128. Association between Fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer
  129. … and feasibility of Fasting -mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active …
  130. Intermittent Fasting suppressed splenic CD205+ G‐MDSC accumulation in a murine breast cancer model by attenuating cell trafficking and inducing apoptosis
  131. GLUT 1 receptor expression and circulating levels of Fasting glucose in high grade serous ovarian cancer
  132. Prevalence of Diabetes and Impaired Fasting Glycemia in Patients With Oral cancer : A Retrospective Study in Hungary
  133. Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study
  134. Postoperative Fasting blood glucose predicts prognosis in stage I-III colorectal cancer patients undergoing resection
  135. Impaired Fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans
  136. … , endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C‐reactive protein, Fasting insulin, and estradiol
  137. Commentary: Intermittent Fasting and Akkermansia Muciniphila Potentiate the Antitumor Efficacy of FOLFOX in Colon cancer
  138. p53 status as effect modifier of the association between pre-treatment Fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients …
  139. … in the glucokinase gene that raises plasma Fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer : findings from a population …
  140. … added value of Fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant …
  141. Fasting inhibits human cancer progression via the epithelial-mesenchymal transition process: Important evidence unraveled
  142. Safety and Feasibility of Intermittent Fasting During Chemotherapy for Breast cancer : A Review of the Literature
  143. Fasting and cancer treatment: A case series
  144. Effect of cancer and Fasting on oxidation of labeled acetate, glucose and glycine to C14O2
  145. Body mass index and impaired Fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment
  146. Abstract B022: Metabolic and immunologic effects of the Fasting mimicking diet in cancer patients
  147. Fasting insulin and risk of cancer related mortality in non-diabetic adults: A dose-response meta-analysis of cohort studies
  148. cancer and Fasting : Can Fasting /Calorie Restriction (CR) or Fasting -Mimicking Diet (FMD) Help Fight cancer ? Molecular Basis of Fasting Response
  149. Significance of low-carbohydrate diets and Fasting in patients with cancer
  150. Fasting blood glucose level in locally advanced non-small cell lung cancer : a new prognostic factor?
  151. Effects of Fasting on the immune system function and its positive effects on the chemotherapy of various types of cancer
  152. Potentiation of crizotinib activity by Fasting cycles in an ALK+ lung cancer model.
  153. Comparison of total N-nitrosamides in Fasting gastric juice from subjects in high and low risk areas for gastric cancer
  154. Long-term patterns of Fasting blood glucose levels and pancreatic cancer incidence
  155. Blood count and Fasting blood glucose level in the assessment of prognosis and survival in advanced cervical cancer
  156. The risk trajectory between preoperative Fasting glucose and common digestive tract cancer -specific mortality in the FIESTA cohort involving 6865 Chinese …
  157. Fasting Abbreviation with Whey Protein Reduces the Occurrence of Postoperative Complications in Patients With Head and Neck cancer : A Randomized Clinical …
  158. The effects of diabetes and Fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy
  159. Cardiopulmonary fitness, adiponectin, chemerin associated Fasting insulin level in colorectal cancer patients
  160. Fasting blood glucose was linearly associated with colorectal cancer risk in the population without self-reported diabetes mellitus history
  161. Correction: The impact of a Fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer : a pilot implementation study
  162. The Complementary Role of Exercise and Fasting in the Treatment of cancer : A Narrative Review of Mechanisms Related to Metabolic Stress Elements
  163. Overnight Fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a …
  164. A feasibility randomised controlled trial of short-term Fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer : SWiFT protocol
  165. Fasting vs. postprandial evaluation of iron deficiency anemia in cancer .
  166. A complementary care study combining flaxseed oil, caffeine, Fasting , and exercise in women diagnosed with advanced ovarian cancer : Findings from a case study
  167. Periodic Fasting mimicking diet delays cancer development and progression
  168. Fasting and glucose-stimulated changes in plasma glucagon in pancreatic cancer : potential biomarkers for detection?
  169. Is perioperative Fasting associated with complications, length of hospital stay and mortality among gastric and colorectal cancer patients? A cohort study
  170. Impaired Fasting glucose in breast cancer survivors of a general hospital at Mexico City: A case series study
  171. The effect of intermittent Fasting on cancer prevention: a systematic review
  172. Multicenter survey of Ramadan Fasting among cancer patient and healthcare professionals in the IR Iran
  173. Effect of 12-week home-based exercise program on Fasting insulin in stage II-III colorectal cancer survivors: A randomized controlled trial.
  174. The effect of Pilates training on isoprostane, Fasting glucose and body composition in women with breast cancer
  175. Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic cancer Risk
  176. Fasting Mimicking Diet promotes immunotherapy-associated changes and inhibits autophagy to promote cancer free survival in Acute Lymphoblastic Leukemia …
  177. Inverse association between Fasting blood glucose and occurrence of gallbladder cancer in type 2 diabetes mellitus patients: a case-control study
  178. Medical synopsis: Nightly Fasting may assist breast cancer patients and other people with cancer
  179. 146P Safety and metabolic effects of Fasting -mimicking diet in breast cancer patients
  180. Determinants of Fasting in Patients with cancer : A Longitudinal Study Using an Integrated Behavior Change Model
  181. Short term Fasting , IGF/insulin-axis and therapy outcome in patients with cancer
  182. … between Fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract cancer
  183. … -term Fasting and the combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer
  184. Fasting and cancer
  185. Abstract P4-16-12: CARE: A pilot study of the effects of short-term Fasting on tolerance to (neo) adjuvant chemotherapy in breast cancer patients
  186. … modified Fasting and the combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer
  187. Food for Thought’closing the audit loop on perioperative Fasting in adult and paediatric cancer patients: 1AP5-8
  188. Effects of Androgen Deprivation Therapy on Blood Lipids and Fasting Blood Glucose in Patients with Prostate cancer
  189. Therapeutic Fasting reduces adverse effects of cancer treatments.
  190. Abstract B76: Evidence of a causal association between Fasting insulin concentrations and endometrial cancer : A Mendelian randomization analysis
  191. Professor Yin Li:“non-tube no Fasting ”—an innovative management of fast-track surgery in patients with esophageal cancer
  192. Multifaceted Effects of Intermittent Fasting in the Treatment and Prevention of Diabetes, cancer and Obesity or Other Chronic Diseases.
  193. P12. 03 The Time of Anti-PD-1 Infusion Improves Survival Outcomes by Fasting Conditions Simulation in Non-Small Cell Lung cancer
  194. Impact of Fasting on 18 F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer
  195. Application of Clinical Nursing Pathway for Rapid Rehabilitation of Tubeless and Fasting Esophageal cancer .
  196. The benefits of Fasting for patients who are immunocompromised and undergoing cancer treatment: An integrative research review
  197. 967P The time of anti-PD-1 infusion improves survival outcomes by Fasting conditions simulation in non-small cell lung cancer
  198. Fasting in cancer patients: A challenge for caregivers
  199. DIFFERENTIAL EFFECTS OF Fasting AND PHARMACOLOGICAL INTERVENTIONS ON cancer AND cancer STEM CELLS
  200. The Effect of a Highly Saturated Fat Diet and Intermittent Fasting Diet on Experimental Colon cancer Development and Some Serum Inflammation Markers in Rats, 1 …
  201. < The> effect of Fasting on the important molecular mechanisms related to cancer treatment
  202. Can Intermittent Fasting Prevent Breast cancer ?
  203. The effect of intermittent Fasting on cancer prevention
  204. Fasting -mimicking diet and risk factors for aging, diabetes, cancer , and cardiovascular disease
  205. Fasting as a Therapeutic Modality in cancer Treatment: A Scoping Review
  206. Abstract C107:[Advocate Abstract] Intermittent Fasting for cancer patients
  207. Review of:” Intermittent Fasting in the prevention and treatment of cancer
  208. Abstract PD5-11: Pilot study to assess prolonged nightly Fasting in breast cancer survivors (LONGFAST)
  209. Potential beneficial effects of intermittent Fasting against cancer risk and management: Novel evidence rendering autophagy as a promising therapeutic target
  210. Fasting used to enhance cancer treatment for patients who are immunocompromised and/or undergoing treatment
  211. Valter Longo, PhD: Differential Stress-The Effects of Fasting on cancer
  212. To fast or not to fast? Intermittent Fasting and cancer
  213. Impaired Fasting glucose in breast cancer survivors of a general hospital at Mexico City: A case series study
  214. Fasting -mimicking diet-based non-toxic combination therapy in cancer treatment: from molecules to bedside
  215. Can Fasting or calorie restriction help my body fight cancer ? Could it also help cancer treatment be more effective?
  216. Intermittent Fasting : The Secret Treatment for Breast cancer ?
  217. Potential beneficial effects of intermittent Fasting against cancer risk and management: Novel evidence rendering autophagy as a promising therapeutic target
  218. EFFECT OF Fasting MIMICKING CONDITIONS ON HORMONE THERAPY EFFICACY AND RESISTANCE ACQUISITION IN BREAST cancer
  219. Effect of intermittent Fasting on prostate cancer tumor growth in a mouse model
  220. Prolonged Overnight Fasting as a Novel Intervention Strategy for Reducing Breast cancer Risk
  221. Association between Fasting serum glucose levels and incidence of colorectal cancer : the Korean cancer prevention study-II
  222. Comment on: Fasting among Muslim cancer patients during the holy month of Ramadan
  223. Long-term history of Fasting blood glucose level and the risk of pancreatic cancer : A nested case-control study.
  224. Abstract CT075: Fasting -mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects
  225. Breaking Mitochondrial Fasting for cancer Treatment: Old Wine in New Bottles
  226. Abstract B10: Fasting blood glucose and bone mineral density in Latina breast cancer survivors
  227. Impaired Fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans
  228. The Association between Fasting Blood Glucose and Liver cancer Risk in Chinese Males: A Prospective Cohort Study
  229. Association between prostate cancer risk, Fasting blood glucose and glycemic control: a large Finnish cohort study
  230. The elevated Fasting palsma glucose levels is not conducive to postoperative recovery in patients with esophageal and cardiac cancer
  231. Commentary: Mendelian randomization analysis identifies body mass index and Fasting insulin as causal risk factors for pancreatic cancer risk
  232. … , Two Colon cancer Patients and One Benign Tumor Patient by Integrated Medical Treatments Mainly Using Low Molecular Weight Fucoidan and a 3-Day Fasting
  233. Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by Fasting
  234. Relationship between Fasting Blood Glucose Level and 18F-FDG PET/CT Biodistribution Quality in Patients with cancer : How Much Should We Concern?
  235. Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal cancer Treatment
  236. Anthropometric indices of adiposity and Fasting glucose metabolism in breast cancer survivors: effects of aerobic physical activity
  237. Fasting and restrictive diet to lose weight among cancer survivors: profiles, sources of nutritional information, knowledges and opinions: results from the NutriNet …
  238. Comparison of the pharmacokinetics of erlotinib administered in complete Fasting and two hours after a meal in non-small cell lung cancer patients
  239. Comparison of total N-nitrosamides in Fasting gastric juices from subjects in high-and low-risk areas for gastric cancer
  240. A prospective study of Fasting lipids and carotid artery status prior to and following treatment for oral and oropharyngeal cancer
  241. Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte …
  242. Aerobic 3-month physical activity program in breast cancer survivors: effects on sleep behavior, anthropometric indices of adiposity and Fasting glucose …
  243. Abstract LB-78: Effects of rapamycin and Fasting -cycles therapy on differential stress resistance and sensitization in breast cancer mouse models
  244. Impact of Sex, Age, Diets, and Fasting in the Redox Potential of the Thiol Disulfide Couple Cysteine and Cysteine (Eh Cys/CySS) and Lung cancer in Mice
  245. Spontaneous GH secretion in the fed and Fasting states in cranially irradiated adult cancer survivors with normal peak GH responses to two provocative tests: does GH …
  246. Abstract# 313: Effect of intermittent Fasting on prostate cancer tumor growth in a mouse model
  247. … Colitis, Stage 2 Lung cancer , Stage 2 Breast cancer , Stage 1 Gastric cancer , Stage 1 Colon cancer and Bronchial Carcinoid Treated with Integrated 3-day Fasting
  248. Abstract P3-09-01: Intermittent Fasting in breast cancer risk and survivorship: Insight from the women’s healthy eating and living study
  249. … Concentrations in Ulcerative Colitis and Pancreatic cancer Patients through Integrative Medical Treatment with Three-day Fasting and Carbohydrate Restriction …
  250. … on gastrin release in patients with gastric cancer and that in men and dogs after gastrectomy. Part I: clinical studies on the Fasting serum gastrin levels in gastric cancer
  251. PD47-02 Fasting BLOOD GLUCOSE AND PROSTATE cancer RISK IN THE FINNISH RANDOMIZED STUDY OF SCREENING FOR PROSTATE cancer
  252. Clinical Report of integrative Medical Treatment with 3 Days Fasting and Carbohydrate-Restricted Diet for a Stage 2 Lung cancer Patient (age 88) Evaluated from …
  253. Abstract P2-11-07: Duration of Fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer : A cohort study …
  254. Evaluation of the Early Metabolic Response induced by 5-Fluorouracil on Mouse Mammary cancer Cells under Fasting conditions using Hyperpolarized 13C-labeled …
  255. … Carolina University, in cooperation with the North American Association for the Study of Obesity, the National Institutes of Health, the American cancer Society, and Eli …
  256. … , Lung-bronchial Carcinoids and Recurrent Pancreatic cancer Cases Treated by Integrative Medicine Coupled with 3 Days Fasting and Carbohydrate Restricted Diet …
  257. … B LYMPHOMAS2 ROLE OF MACROPHAGES IN HUMAN B LYMPHOMA PROGRESSION3 INTERACTION OF BREAST cancer WITH FOLLICULAR DENDRITIC …
  258. Fasting -mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity
  259. Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose …
  260. Effects of anesthetic agents and Fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice
  261. Combined intermittent Fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
  262. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice
  263. Wheel running improves Fasting ‐induced AMPK signaling in skeletal muscle from tumor‐bearing mice
  264. L-Carnosine supplementation attenuated Fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor–α levels in patients with type 2 …
  265. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and Fasting plasma glucose in young, older, and diabetic Japanese men
  266. Genetic polymorphisms of tumor necrosis factor-α modify the association between dietary polyunsaturated fatty acids and Fasting HDL-cholesterol and apo AI …
  267. Evidence that tumor necrosis factor-alpha [ndash] induced hyperinsulinemia prevents decreases of circulating leptin during Fasting in rats
  268. Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces Fasting hypoglycemia
  269. The growth of tumor cells under normal and Fasting conditions
  270. The diagnosis of Fasting hypoglycemia due to an islet-cell tumor obscured by a highly specific insulin assay
  271. Polymorphism Ncol in tumor necrosis factor B is associated with Fasting glycemia and lipid parameters in healthy non-obese caucasian subjects.
  272. Short-term supplementation of a moderate carbohydrate diet with psyllium reduces Fasting plasma insulin and tumor necrosis factor-α in patients with type 2 diabetes …
  273. Effects of Fasting on growth and glycolysis of the Ehrlich ascites tumor
  274. Comprehensive modulation of tumor progression and regression with periodic Fasting and refeeding circles via boosting IGFBP-3 loops and NK responses
  275. Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in Fasting and non-Fasting rats
  276. The anti-tumor efficacy of 20 (S)-protopanaxadiol, an active metabolite of ginseng, according to Fasting on hepatocellular carcinoma
  277. Effect of intermittent Fasting during Ramadan on Visfatin, Adiponectin and tumor necrotizing factor-alpha in healthy Muslim individuals
  278. Natural defense systems of Fasting rats against tumor cells
  279. Fasting chemosensitizes tumor cells by affecting their metabolism
  280. Fasting hypoglycemia in solitary fibrous tumor of the peritoneum: a diagnostic clue for an emergent situation
  281. Fasting plasma leptin, monocyte chemoattracting protein-1 (MCP-1/CCL2) and α-tumor necrosis factor receptor 2 (α-TNFR-2) concentrations in glucose tolerant and …
  282. Interaction between Fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract …
  283. Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center
  284. The Relationship between Baseline Fasting Blood Glucose and Tumor Embolus in Predicting the Postoperative Prognosis of 4330 Patients with Gastrointestinal Tract …
  285. Commentary: Fasting -Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
  286. Exercise Improves the Fasting Regulation of Skeletal Muscle Protein Synthesis in Tumor Bearing Mice
  287. … and One Benign Tumor Patient by Integrated Medical Treatments Mainly Using Low Molecular Weight Fucoidan and a 3-Day Fasting , Carbohydrate Restricted Diet …
  288. … ARTHRITISP065. WRIST MAGNETIC RESONANCE IMAGING (MRI) FINDINGS IN JUVENILE IDIOPATHIC ARTHRITIS (JIA) P066. Fasting SERUM LEPTIN LEVELS …
  289. Tumor Necrosis Factor-[Alpha] Gene G-308A Polymorphism, Insulin Resistance, and Fasting Plasma Glucose in Japanese Men
  290. … with 3 Days Fasting and Carbohydrate-Restricted Diet for a Stage 2 Lung cancer Patient (age 88) Evaluated from Values of Ketone Body, Serotonin and Tumor …
  291. … and Bronchial Carcinoid Treated with Integrated 3-day Fasting and Carbohydrate-Restricted Diet, and Clinical Improvement Reports of Tumor Markers (CEA, Anti-p53 …
  292. … LYMPH NODE STROMAL CELLS ENHANCE TUMOR FORMATION OF COLON cancer STEM CELLS ISOLATED FROM PATIENT SPECIMENS5 TUMOR …
Shopping Cart
Scroll to Top